Market News & Trends
Novo Nordisk & Emisphere Announce License Agreement to Develop Oral Formulation of Insulin for $57.5 Million
Emisphere Technologies, Inc. and Novo Nordisk A/S recently announced they have entered into an exclusive development and license agreement to develop and commercialize oral formulations…
January 3, 2011
Omeros Corporation Announces Positive Phase I/II Clinical Results of OMS201
Omeros Corporation, a biopharmaceutical company committed to discovering, developing, and commercializing products focused on inflammation and disorders of the central nervous system, recently announced results…
January 3, 2011
*Latest Events
Pre-Filled East Coast 2018 April 10-12 Boston, MA Pre Filled Syringes East Coast April 11 - 12 Boston, MA INTERPHEX April 17-19 New York City…
January 1, 1900
